Advertisement

Picture EBD Group Biotech Showcase 2025 San Francisco BTS25 650x100px
Organisation › Details

RDDT (AU)

vivoPharm is a growing and profitable technology leader and innovator in preclinical in vivo oncology and other research services. It has developed more than 70 fully characterized and validated cancer cell lines used in oncology pharmaceutical research. vivoPharm has pioneered the development of proprietary orthotopic methods (site-specific grafting of tissues) and other specialized in vivo tumor models. vivoPharm has developed an expanding global base of customers both in the pharmaceutical and emerging biotech sectors. The Company is led by Dr. Ralf Brandt, a recognized cancer biologist, who, prior to founding vivoPharm, was Head of Tumor Biology at Novartis AG. *

 

Period Start 2016-03-31 existent
  Group vivoPharm (Group)
Product Industry  oncology
Person Person Brandt, Ralf (vivoPharma 201504 CEO + Founder before Head of Tumor Biology at Novartis AG)
     
Region Region Bundoora VIC
  Country Australia
  Street 240 Plenty Road
Level 3, Suite S29
  City 3083 Bundoora VIC
  Tel +61-3-99888-1800
    Address record changed: 2020-12-02
     
Basic data Employees n. a.
     
    * Document for »About Section«: 
     
   
Record changed: 2023-07-10

Advertisement

Picture EBD Group Biotech Showcase 2025 San Francisco BTS25 650x200px

To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to info@iito.de and simply fill the subject line with the word »MSC Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at Life-Sciences-Germany.com and Life-Sciences-Europe.com

Advertisement

Picture EBD Group World of Partnering Opportunities 650x300px




» top